Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.

被引：2
|
作者：
Westdorp, Harm
van Oort, Inge M.
Creemers, Jeroen H. A.
Schreibelt, Gerty
Mehra, Niven
de Goede, Anna L.
Hulsbergen-Van De Kaa, Christina
Figdor, Carl G.
Witjes, Alfred
Aarntzen, Erik H. J. G.
Mus, Roel D. M.
Gotthardt, Martin
Barentsz, Jelle O.
De Vries, Jolanda
Gerritsen, Winald R.
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[2] Radboud Inst Mol Life Sci, Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页数：1
相关论文
共 50 条
  • [31] MLL translocation in two castration-resistant prostate cancer patients
    Chowdry, Rajasree Pia
    Ledet, Elisa
    Asinghe, Lahiru Ran.
    Sartor, Alton Oliver
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (05) : 8483 - 8486
  • [32] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [33] Experience with fulvestrant acetate in castration-resistant prostate cancer patients
    Gasent Blesa, J. M.
    Alberola Candel, V.
    Giner Marco, V.
    Giner-Bosch, V.
    Provencio Pulla, M.
    Laforga Canales, J. B.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1131 - 1132
  • [34] IMPROVED SURVIVAL PROSPECTS FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
    Kirby, Roger S.
    Fitzpatrick, John M.
    BJU INTERNATIONAL, 2011, 107 (05) : 697 - 700
  • [35] Immunohybridoma cell-based vaccine for the treatment of patients with castration-resistant prostate cancer
    Hawlina, S.
    Chowdhury, H. H.
    Gabrijel, M.
    Bobnar, S. Trkov
    Kreft, M.
    Lenart, G.
    Cukjati, M.
    Kopitar, A. N.
    Ihan, A.
    Lezaic, L.
    Gamek, M.
    Kmetec, A.
    Jeras, M.
    Zorec, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S2 - S2
  • [36] Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
    Lin, Ting-Ting
    Chen, Ye-Hui
    Wu, Yu-Peng
    Chen, Shao-Zhan
    Li, Xiao-Dong
    Lin, Yun-Zhi
    Chen, Shao-Hao
    Zheng, Qing-Shui
    Wei, Yong
    Xu, Ning
    Xue, Xue-Yi
    JOURNAL OF CANCER, 2019, 10 (22): : 5608 - 5613
  • [37] The DNA methylome of castration-resistant prostate cancer
    Kleb, Brittney N.
    Estecio, Marcos
    Zhang, Jiexin
    Tzelepi, Vasso
    Chung, Woonbok
    Maity, Sankar
    Logothetis, Christopher
    Troncoso, Patricia
    Navone, Nora
    Jelinek, Jaroslav
    Liang, Shoudan
    Issa, Jean-Pierre
    Aparicio, Ana
    CANCER RESEARCH, 2012, 72
  • [38] Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1174 - 1175
  • [39] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [40] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
12345